Dr. Shobha Swaminathan is an associate professor at Rutgers New Jersey Medical School and medical director of infectious diseases practice at University Hospital. This week, she is better known for being the principal investigator for the Moderna Phase 3 coronavirus vaccine clinical trial at the school. On Monday, Moderna announced its vaccine had a 94.5% efficacy rate — the second incredibly positive vaccine announcement in the last 10 days. Swaminathan, who has been involved in a handful of vaccine studies, twice serving as the principal investigator, gave ROI-NJ some insights into how this trial was different from the others in speed and size — and why concerns about safety may be unfounded. To read the full story.
Home / News / She was principal investigator of Moderna COVID-19 vaccine trial in Newark. Her insights will inform you
Recent Posts
- NJ ACTS Special Populations Virtual Seminar on 9/24 at 12pm – Register Now
- NJ ACTS CREST (R25) Funded
- NJ ACTS Workforce Development Internship Fall 2024 – Deadline Today
- Rutgers Health Researchers Find Disparities in Outcomes of Hospice Discharges.
- NJIT Researchers Close in on New Technology for Objectively Measuring Pain.
Categories
- Community (1,990)
- Covid (974)
- CTO Events (1)
- News (2,536)
- Pilots (20)